Close
American Drug Delivery & Formulation Summit
Xylem

News

What Medical Supplies Should Companies Provide To Employees

The COVID-19 pandemic has stopped most businesses with the strict guideline of social distancing and staying at home, thus many have lost their livelihood. Those companies that are still open are now left with the responsibility to protect their...

Coriolis Pharma Expands ATMP Development Facilities

Coriolis Pharma, a provider of research and development of for (bio)pharmaceutical drugs, is expanding its advanced therapy medicinal products (ATMP) development facilities under biosafety level S2 (BSL2 / S2). Re-construction of an existing building near the Coriolis headquarters started in...

Vectura, Incannex Enter Preclinical Services Agreement

Vectura Group plc, an inhalation CDMO, has signed an agreement with Incannex Healthcare Ltd., an Australian cannabinoid medicines development company, to provide preclinical development services for IHL-216A, Incannexโ€™s proprietary inhaled drug product for the treatment of traumatic brain injury...

UNC researchers develop potential universal coronavirus vaccine

Scientists at the University of North Carolina Gillings School of Global Public Health have developed a universal vaccine that protected mice not just against COVID-19 but also other coronaviruses and triggered the immune system to fight off a dangerous...

Etihad Cargo and EFL Global successfully deliver vital antiretroviral drugs to Brazil

Etihad Cargo, the cargo and logistics arm of Abu Dhabiโ€™s Etihad Aviation Group, and global supply chain company EFL Global, have successfully carried a vital consignment of antiretroviral drugs from India to Brazil. The shipment, which weighed more than 55,000kg,...

Schreiner MediPharm and Plas-Tech Engineering Collaborate to Offer Full Service First-opening Indication for Prefilled Syringes

Schreiner MediPharm, a Germany-based global provider of innovative functional label solutions for the healthcare industry, and Plas-Tech Engineering, an expert in prefillable polymer syringes, have entered into a collaborative partnership for Cap-Lock โ€“ an innovative first-opening indication for prefilled...

Novo Nordisk Partners With Seattle Biopharm to Research, Develop Obesity Therapies

Seattle-based clinical-stage biopharmaceutical company Lumen Bioscience is teaming up with Novo Nordisk to explore research and development opportunities within obesity, among other metabolic disorders. The collaboration will harness Lumen's drug development and manufacturing platform alongside Novo Nordisk's experience in R&D...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป